D'Aquila RT - Search Results

1

Epidemic human immunodeficiency virus (HIV) infection among intravenous drug users (IVDU).

D'Aquila RT, Williams AB. D'Aquila RT, et al. Yale J Biol Med. 1987 Nov-Dec;60(6):545-67. Yale J Biol Med. 1987. PMID: 3324506 Free PMC article. Review.

2

Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.

Williams AB, McNelly EA, Williams AE, D'Aquila RT. Williams AB, et al. AIDS Care. 1992;4(1):35-41. doi: 10.1080/09540129208251618. AIDS Care. 1992. PMID: 1314099

3

Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users.

D'Aquila RT, Peterson LR, Williams AB, Williams AE. D'Aquila RT, et al. J Acquir Immune Defic Syndr (1988). 1989;2(5):503-13. J Acquir Immune Defic Syndr (1988). 1989. PMID: 2795451

4

Prevalence of HTLV-III infection among New Haven, Connecticut, parenteral drug abusers in 1982-1983.

D'Aquila R, Williams AB, Kleber HD, Williams AE. D'Aquila R, et al. N Engl J Med. 1986 Jan 9;314(2):117-8. doi: 10.1056/NEJM198601093140211. N Engl J Med. 1986. PMID: 3941684 No abstract available.

5

HIV infection in intravenous drug abusers.

Williams AB, D'Aquila RT, Williams AE. Williams AB, et al. Image J Nurs Sch. 1987 Winter;19(4):179-83. doi: 10.1111/j.1547-5069.1987.tb00003.x. Image J Nurs Sch. 1987. PMID: 3692520 No abstract available.

6

A second case of the acquired immunodeficiency syndrome due to human immunodeficiency virus type 2 in the United States: the clinical implications.

Ruef C, Dickey P, Schable CA, Griffith B, Williams AE, D'Aquila RT. Ruef C, et al. Am J Med. 1989 Jun;86(6 Pt 1):709-12. doi: 10.1016/0002-9343(89)90451-8. Am J Med. 1989. PMID: 2729324 Free article. No abstract available.

7

Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.

Coombs RW, Welles SL, Hooper C, Reichelderfer PS, D'Aquila RT, Japour AJ, Johnson VA, Kuritzkes DR, Richman DD, Kwok S, Todd J, Jackson JB, DeGruttola V, Crumpacker CS, Kahn J. Coombs RW, et al. J Infect Dis. 1996 Oct;174(4):704-12. doi: 10.1093/infdis/174.4.704. J Infect Dis. 1996. PMID: 8843206

8

HIV-1 reverse transcriptase/ribonuclease H: high level expression in Escherichia coli from a plasmid constructed using the polymerase chain reaction.

D'Aquila RT, Summers WC. D'Aquila RT, et al. J Acquir Immune Defic Syndr (1988). 1989;2(6):579-87. J Acquir Immune Defic Syndr (1988). 1989. PMID: 2479733

9

Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.

Lathey JL, Hughes MD, Fiscus SA, Pi T, Jackson JB, Rasheed S, Elbeik T, Reichman R, Japour A, D'Aquila RT, Scott W, Griffith BP, Hammer SM, Katzenstein DA. Lathey JL, et al. J Infect Dis. 1998 Mar;177(3):617-24. doi: 10.1086/514250. J Infect Dis. 1998. PMID: 9498440 Clinical Trial.

10

Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city.

Footer KHA, Lim S, Rael CT, Greene GJ, Carballa-Diéguez A, Giguere R, Martinez M, Bockting W, D'Aquila R, Sherman SG. Footer KHA, et al. AIDS Care. 2019 Oct;31(10):1207-1213. doi: 10.1080/09540121.2019.1587352. Epub 2019 Mar 1. AIDS Care. 2019. PMID: 30822101 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page